Maria R Matarazzo
Overview
Explore the profile of Maria R Matarazzo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
447
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lullo V, Cecere F, Batti S, Allegretti S, Morone B, Fioriniello S, et al.
Front Immunol
. 2024 Jul;
15:1419748.
PMID: 39040103
Immunodeficiency, Centromeric instability and Facial anomalies (ICF) syndrome is a rare genetic disorder characterized by variable immunodeficiency. More than half of the affected individuals show mild to severe intellectual disability...
2.
Verma A, Krishnan V, Cecere F, DAngelo E, Lullo V, Strazzullo M, et al.
Biomolecules
. 2023 Dec;
13(12).
PMID: 38136588
Parent-of-origin-dependent gene expression of a few hundred human genes is achieved by differential DNA methylation of both parental alleles. This imprinting is required for normal development, and defects in this...
3.
Ghinassi B, Matarazzo M, Di Ruscio A
Front Cell Dev Biol
. 2023 Apr;
11:1164429.
PMID: 37009473
No abstract available.
4.
Krishnan V, Morone B, Toubiana S, Krzak M, Fioriniello S, Della Ragione F, et al.
Genome Res
. 2023 Feb;
33(2):169-183.
PMID: 36828588
Bi-allelic hypomorphic mutations in disrupt DNA methyltransferase activity and lead to immunodeficiency, centromeric instability, facial anomalies syndrome, type 1 (ICF1). Although several ICF1 phenotypes have been linked to abnormally hypomethylated...
5.
Fico A, Di Croce L, Matarazzo M
Epigenomes
. 2021 Dec;
4(4).
PMID: 34968305
The epigenome refers to the entirety of DNA methylations, histone modifications, nucleosome occupancy, and coding and non-coding RNAs (and their modifications) in different cell types [...].
6.
Fioriniello S, Csukonyi E, Marano D, Brancaccio A, Madonna M, Zarrillo C, et al.
Stem Cell Reports
. 2020 Dec;
15(6):1317-1332.
PMID: 33296675
Methyl-CpG binding protein 2 (MeCP2) has historically been linked to heterochromatin organization, and in mouse cells it accumulates at pericentric heterochromatin (PCH), closely following major satellite (MajSat) DNA distribution. However,...
7.
Toubiana S, Gagliardi M, Papa M, Manco R, Tzukerman M, Matarazzo M, et al.
Elife
. 2019 Nov;
8.
PMID: 31738163
DNA methyltransferase 3B (DNMT3B) is the major DNMT that methylates mammalian genomes during early development. Mutations in human disrupt genome-wide DNA methylation patterns and result in ICF syndrome type 1...
8.
DAniello C, Cermola F, Palamidessi A, Wanderlingh L, Gagliardi M, Migliaccio A, et al.
Cancer Res
. 2019 May;
79(13):3235-3250.
PMID: 31061065
Collagen prolyl hydroxylation (CPH), which is catalyzed by prolyl 4-hydroxylase (P4H), is the most prevalent posttranslational modification in humans and requires vitamin C (VitC). Here, we demonstrate that CPH acts...
9.
Gagliardi M, Strazzullo M, Matarazzo M
Front Cell Dev Biol
. 2018 Nov;
6:140.
PMID: 30406101
DNA methylation plays important roles in gene expression regulation and chromatin structure. Its proper establishment and maintenance are essential for mammalian development and cellular differentiation. DNMT3B is the major DNA...
10.
Gatto S, Gagliardi M, Franzese M, Leppert S, Papa M, Cammisa M, et al.
Nucleic Acids Res
. 2017 Mar;
45(10):5739-5756.
PMID: 28334849
Hypomorphic mutations in DNA-methyltransferase DNMT3B cause majority of the rare disorder Immunodeficiency, Centromere instability and Facial anomalies syndrome cases (ICF1). By unspecified mechanisms, mutant-DNMT3B interferes with lymphoid-specific pathways resulting in...